company

ONCOGENE AS

2007 KJELLER

Return on Equity
125 %
Current Ratio
0,79
Debt-to-Equity Ratio
−0
Key figures (NOK)2022
Revenue78 000
Net Income−5 000
Total Assets90 000
Total Equity−4 000
Income (NOK)2022
Revenue78 000
Expenditure83 000
Operating Profit−5 000
Financial Income0
Financial Costs0
Financial Balance0
Earnings Before Tax−5 000
Tax0
Net Income−5 000
Balance (NOK)2022
Total Fixed Assets15 000
Total Current Assets75 000
Total Assets90 000
Total Retained Equity−34 000
Total Equity−4 000
Total Long-Term Debt0
Total Current Debt95 000
Total Equity and Debt90 000
Cash flow (NOK)2022
Sales Income62 000
Other Income16 000
Revenue78 000
Cost of Goods Sold0
Salary Costs64 000
Depreciation0
Impairment0
Expenditure83 000
Operating Profit−5 000
Financial Income0
Financial Costs0
Financial Balance0
Dividends0
Net Income−5 000
Balance details (NOK)2022
Goodwill0
Total Intangible Assets15 000
Real Eastate0
Machinery and Plant Facilities0
Fixtures0
Total Tangible Assets0
Total Fiancial Fixed Assets0
Total Fixed Assets15 000
Stock0
Total Investments0
Cash, Bank25 000
Total Current Assets75 000
Total Assets90 000
Total Equity−4 000
Short-Term Group Debt0
Total Long-Term Debt0
Creditors0
Unpaid Taxes5 000
Dividends0
Other Current Debt89 000
Total Current Debt95 000
Total Equity and Debt90 000
Financial indicators2022
Return on Equity125 %
Debt-to-Equity Ratio−0
Operating Profit Margin−6,41 %
Current Ratio0,79
Quick Ratio0,79
Equity Ratio−0,04
Gross Profit Margin100 %
RotateRotate your device to see the full table
HomeIndustriesNew CompaniesAbout
🇳🇴Norsk🇬🇧English